Streptococcal pharyngitis, commonly called strep throat, is an infection of the pharynx caused by Streptococcus pyogenes, a gram-positive group A beta-hemolytic streptococcus [1]. Humans serve as the primary natural reservoir for group A streptococcus [1]. The infection presents as inflammation of the throat with characteristic clinical findings that distinguish it from viral pharyngitis [1].
Disease overview
BacterialGroup A streptococcal pharyngitis
A族链球菌性咽炎
Streptococcal pharyngitis, also known as strep throat, is a bacterial infection of the pharynx caused by Streptococcus pyogenes, a gram-positive group A streptococcus [1]. Common symptoms include fever, sore throat, red tonsils, enlarged lymph nodes, headache, and nausea or vomiting, with some patients developing scarlet fever characterized by a sandpaper-like rash [1]. Symptoms typically appear one to three days after exposure and persist for seven to ten days [1]. Penicillin remains the first-line antibiotic therapy for group A streptococcal pharyngitis, though various broad-spectrum antibiotics continue to be prescribed in clinical practice [2].
Read the full clinical and epidemiological profile6
The clinical presentation typically includes fever, sore throat, erythematous tonsils, and tender cervical lymphadenopathy in the anterior neck [1]. Additional manifestations may include headache, nausea, and vomiting [1]. Some patients develop scarlet fever, characterized by a diffuse sandpaper-textured rash [1]. Symptoms usually manifest one to three days after exposure and resolve within seven to ten days without treatment [1]. Some individuals may carry the bacteria asymptomatically [1].
Strep throat is a common bacterial infection in children [1]. It accounts for 15–40% of sore throats among children and 5–15% among adults [1]. Incidence shows seasonal variation, with cases being more frequent in late winter and early spring [1]. Transmission is facilitated by crowding conditions found in military and school settings [1].
The infection spreads through respiratory droplets from infected individuals during talking, coughing, or sneezing, or by direct contact with contaminated secretions [1]. Transmission can also occur through touching surfaces with infectious droplets and subsequently touching the mouth, nose, or eyes, or through contact with infected skin or sores [1]. Moist bacteria on objects such as toothbrushes may remain viable for up to fifteen days, though dried bacteria in dust are not considered infectious [1]. Food contamination is a rare but documented transmission route [1]. Close, direct contact with an infected person significantly increases transmission risk, particularly in crowded environments [1].
Primary prevention measures include frequent hand washing and avoiding sharing of eating utensils [1]. No vaccine is currently available for streptococcal pharyngitis [1]. For individuals with recurrent infections (more than three episodes per year), tonsillectomy may represent a reasonable preventive option, though benefits are modest and episodes often decrease naturally over time regardless of intervention [1]. Treatment of asymptomatic contacts or carriers is not recommended given the low risk of transmission and complications [1]. Infected individuals should remain isolated from others until fever resolves and for at least twelve hours after initiating antibiotic therapy [1].
- 1Wikipedia contributors. Streptococcal pharyngitis - Wikipedia [Internet]. Wikipedia. cited 3 Sept 2026.Available from: https://en.wikipedia.org/wiki/Streptococcal_pharyngitis
- 2Sun X et al. Efficacy and safety of 24 antibiotics for group A streptococcal pharyngitis: a network meta-analysis of 64 randomized controlled trials. Front Public Health. 2026. PMID: 42440760. doi: 10.3389/fpubh.2026.1848949.PubMed: https://pubmed.ncbi.nlm.nih.gov/42440760/
- J02.0
- 1B51
Coverage
Reporting countries and regions
Trends by reporting country
Monthly patterns over time
Research Radar
Recent related research
Overview of 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal (GAS) Pharyngitis: Risk Assessment Using Clinical Scoring Systems in Children and Adults
Clinical Infectious Diseases
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal Pharyngitis: Risk Assessment Using Clinical Scoring Systems in Children and Adults
Clinical Infectious Diseases
Literature links are provided for discovery and do not alter or validate the surveillance series above.
Data access
Page dataset index with source links and update metadata.
Official sourcesAuthority, cadence, notes6
Iceland Directorate of Health Annual Dashboard
Iceland
National annual case notifications by disease. Published values can be revised retrospectively and remain annual period totals.
Iceland Directorate of Health STI Dashboard
Iceland
Monthly STI diagnosis facts from laboratory and registry surveillance; the official dashboard is published on a quarterly schedule.
Iceland Directorate of Health Respiratory Dashboard
Iceland
ISO-week respiratory diagnosis counts. Hospitalizations, samples, and vaccination indicators are separate measures and are not counted as diagnoses.
Iceland Directorate of Health Historical Registry
Iceland
Historical official registry tables for 1997–2021, with annual totals and disease-specific monthly notification facts retained at source grain.
Iceland Directorate of Health Legacy ICD Monthly
Iceland
Historical Saga EHR ICD encounter counts for 1997–2020. This clinical measure is non-comparable with registry notifications and is kept separate.
JP NIID Weekly
Japan
Japan weekly infectious disease surveillance via NIID/JIHS.